EUVIMEDSkopri EUVIMED
Multizentrische StudieBeobachtungsstudieOpen access · CC BY-NC 4.0

Association Between Viral Replication Activity and Postoperative Recurrence of HBV ‐Related Hepatocellular Carcinoma

Subin Heo iD, Jiwon Yang, Jeayeon Park, Rex Wan-Hin Hui iD, Byeong Geun Song iD, In-Hye Song, Young-In Yoon, Tan-To Cheung, Sung Won Chung, Jonggi Choi, Danbi Lee, Ju Hyun Shim iD and 6 more

Alimentary Pharmacology & Therapeutics · 2025

DOI: 10.1111/apt.70085 ↗

At a glance

Multizentrische Studie in Alimentary Pharmacology & Therapeutics, 2025. Written by Subin Heo and 17 co-authors. Institution: Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. Major MEDLINE topics: Carcinoma, Hepatocellular, Hepatitis B virus, Hepatitis B, Chronic, Liver Neoplasms. Cited 12 times so far (Crossref); 39 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: National Cancer Center, National Evidence-based Healthcare Collaborating Agency, National Research Foundation of Korea.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background

Baseline viral replication activity influences the risk of hepatocellular carcinoma (HCC) development in patients with chronic hepatitis B virus (HBV) infection.

Aims

To evaluate the impact of baseline viral replication activity on recurrence in HBV‐related HCC after curative resection.

Methods

A multinational retrospective cohort of 2384 patients with very early or early‐stage HBV‐related HCC who consecutively underwent curative resection and received antiviral therapy (AVT) between 2010 and 2018 was analysed. Patients were categorised into ongoing‐AVT (previously on AVT with viral suppression) and initiation‐AVT (initiated AVT at the time of resection) groups. HCC recurrence was compared between these two groups based on baseline viral replication activity.

Results

During a median follow‐up of 4.9 years, 1188 (49.8%) patients developed recurrence. Multivariable analysis showed similar recurrence risk between the ongoing‐AVT and initiation‐AVT groups (HR, 1.09; 95% CI, 0.96–1.24). However, in cirrhotic patients, the initiation‐AVT group had a higher recurrence risk than the ongoing‐AVT group (HR, 1.22; 95% CI, 1.02–1.45) but not in non‐cirrhotic patients (HR, 0.90; 95% CI, 0.73–1.09). Intriguingly, in the non‐cirrhotic initiation‐AVT group, a parabolic association was observed between baseline HBV DNA levels and the risk of recurrence, with those having 5–6 log 10 IU/mL HBV DNA levels showing significantly higher recurrence risk compared to the ongoing‐AVT group (HR, 1.78; 95% CI, 1.32–2.42).

Conclusions

The association between HBV replication activity and the risk of HCC recurrence varied depending on cirrhosis, providing important insights for optimising the timing of AVT and post‐operative surveillance strategies.

Subjects

MeSH terms (MEDLINE)

Carcinoma, HepatocellularHepatitis B virusHepatitis B, ChronicLiver NeoplasmsNeoplasm Recurrence, LocalVirus ReplicationAdultAgedFemaleHumansMaleMiddle AgedAntiviral AgentsRetrospective StudiesRisk Factors

Author keywords

HBV DNAclonal expansioninflammationliver cancernucleos(t)ide analogues

Substances

Antiviral Agents

Authors and institutions

  • Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Department of Gastroenterology, Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
  • Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Pokfulam, Hong Kong.
  • Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.

ORCID profiles: Subin Heo, Rex Wan-Hin Hui, Byeong Geun Song, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Wai-Kay Seto, Won-Mook Choi

Funding

  • National Cancer Center
  • National Evidence-based Healthcare Collaborating Agency
  • National Research Foundation of Korea

Cite

APA

Heo, S., Yang, J., Park, J., Hui, R. W., Song, B. G., Song, I. H., Yoon, Y. I., Cheung, T. T., Chung, S. W., Choi, J., Lee, D., Shim, J. H., Kim, K. M., Lim, Y. S., Lee, H. C., Seto, W. K., Lee, J. H., & Choi, W. M. (2025). Association Between Viral Replication Activity and Postoperative Recurrence of HBV ‐Related Hepatocellular Carcinoma. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.70085

Vancouver

Heo S, Yang J, Park J, Hui RW, Song BG, Song IH, et al. Association Between Viral Replication Activity and Postoperative Recurrence of HBV ‐Related Hepatocellular Carcinoma. Alimentary Pharmacology & Therapeutics. 2025. doi:10.1111/apt.70085

BibTeX
@article{Heo2025,
  author = {Heo, Subin and Yang, Jiwon and Park, Jeayeon and Hui, Rex Wan-Hin and Song, Byeong Geun and Song, In-Hye and Yoon, Young-In and Cheung, Tan-To and Chung, Sung Won and Choi, Jonggi and Lee, Danbi and Shim, Ju Hyun and Kim, Kang Mo and Lim, Young-Suk and Lee, Han Chu and Seto, Wai-Kay and Lee, Jeong-Hoon and Choi, Won-Mook},
  title = {Association Between Viral Replication Activity and Postoperative Recurrence of HBV ‐Related Hepatocellular Carcinoma},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2025},
  doi = {10.1111/apt.70085}
}
Start for free →